Cardiovascular risk and lupus disease

M Boucelma1, F Haddoum, H Chaudet

  • 1Department of Internal Medicine, Mohamed Lamine Debaghine Hospital, Algiers, Algeria. mboucelma@yahoo.fr

Insights

Young women with Systemic Lupus Erythematosus (SLE) exhibit significant subclinical atherosclerosis and cardiovascular risk factors, necessitating early detection and intervention to prevent vascular events.

Area of Science:

  • Rheumatology
  • Cardiology
  • Vascular Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in Systemic Lupus Erythematosus (SLE) patients.
  • Subclinical atherosclerosis and its associated risk factors are prevalent in SLE.
  • Early detection of CVD risk in SLE is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate subclinical atherosclerosis in SLE patients.
  • To determine the prevalence of cardiovascular risk factors (CVRF) in SLE.
  • To identify associations between CVRF, atherosclerosis, and cardiovascular events in SLE.

Main Methods:

  • 153 SLE patients underwent physical examination, carotid and leg artery ultrasound, and ankle-brachial pressure index (ABPI) measurement.
  • Myocardial tomoscintigraphy was performed in 94 patients.
  • Laboratory tests included lipids, homocysteine, glucose, and vascular cell adhesion molecules (VCAM-I).

Main Results:

  • High prevalence of CVRF: dyslipidemia (62.8%), hyperhomocysteinemia (55%), obesity (39%), hypertension (35%).
  • Subclinical atherosclerosis detected: carotid atheroma (20.9%), femoral/popliteal artery calcification (70%).
  • Abnormalities linked to CVD events: perfusion defects (P<0.01-0.02), hypertension (P<0.0006), carotid plaques (P<0.01).

Conclusions:

  • Young women with SLE frequently have subclinical atherosclerosis.
  • SLE patients exhibit a high burden of cardiovascular risk factors.
  • Proactive screening for atherosclerosis and CVRF is essential in SLE management.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...